Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Clinical trial NCT00622726 · UNKNOWN
Trial details
- NCT number
- NCT00622726
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-08-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.